(Cautious) optimism in FSHD drug development
Posted on January 16th, 20231/16/23
Patients are critical in helping to transform optimism into reality by Ken Kahtava, Chief Business Officer, FSHD Society Breakthroughs in FSHD research have identified the primary mechanism that causes FSHD. […]
Filed under: FSHD Research
